- within Coronavirus (COVID-19) and Law Department Performance topic(s)
Hosts Megan Beaver and Savanna Williams talk to Rachel Park and Lisa Umans about the regulation of the organ procurement industry, recent congressional interest in the space, and the latest updates from the Centers for Medicare and Medicaid Services (CMS). For more information on CMS's regulation governing organ procurement organizations (OPO) that will determine ongoing OPO participation this year, as well as its recent proposed rule governing OPO oversight, please visit a recentclient alert and Law360 article authored by Rachel Park and Troy Barsky.
This podcast episode features the following speakers:
- Rachel Park is a senior counsel in Crowell & Moring's Washington, D.C. office and a member of the firm's Health Care Group. She advises clients on a wide array of health care matters, including Medicare and Medicaid reimbursement, managed care litigation, and health care fraud investigations and oversight. Prior to joining Crowell, she served for 24 years at the U.S. Department of Health and Human Services (HHS), most recently as principal deputy general counsel, the highest-level nonpolitical appointee in the HHS Office of the General Counsel.
- Lisa Umans is a partner in Crowell & Moring's New York office and a member of the firm's White Collar and Regulatory Enforcement group and Financial Services group. She represents large institutional clients and individuals in federal and state regulatory and criminal investigations conducted by grand juries, congressional committees, and domestic and international law enforcement and regulatory agencies including the Department of Justice's Criminal and Antitrust Divisions, U.S. Attorney's Offices, Securities and Exchange Commission (SEC), the Commodity Futures Trading Commission (CFTC), the Financial Industry Regulatory Authority (FINRA), and various State Attorneys General.
Payers, Providers, and Patients – Oh My! is Crowell & Moring's health care podcast, discussing legal and regulatory issues that affect health care entities' in-house counsel, executives, and investors.
Click below to listen or access from one of these links:
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
[View Source]
